Flusoxolol
|
|
| Names
|
| IUPAC name
(2S)-1-[4-[2-[2-(4-Fluorophenyl)ethoxy]ethoxy]phenoxy]-3-(propan-2-ylamino)propan-2-ol
|
| Identifiers
|
|
|
|
|
|
|
| ChEMBL
|
|
| ChemSpider
|
|
|
|
|
| UNII
|
|
InChI=1S/C22H30FNO4/c1-17(2)24-15-20(25)16-28-22-9-7-21(8-10-22)27-14-13-26-12-11-18-3-5-19(23)6-4-18/h3-10,17,20,24-25H,11-16H2,1-2H3/t20-/m0/s1 Key: CYCXZGUVPDRYLG-FQEVSTJZSA-N InChI=1/C22H30FNO4/c1-17(2)24-15-20(25)16-28-22-9-7-21(8-10-22)27-14-13-26-12-11-18-3-5-19(23)6-4-18/h3-10,17,20,24-25H,11-16H2,1-2H3/t20-/m0/s1 Key: CYCXZGUVPDRYLG-FQEVSTJZBA
|
CC(C)NC[C@@H](COc1ccc(cc1)OCCOCCc2ccc(cc2)F)O
|
| Properties
|
|
|
C22H30FNO4
|
| Molar mass
|
391.483 g·mol−1
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references
|
Flusoxolol is a selective beta-1 receptor blocker.[1]
References
- ^ Sysoliatina, NA (1992). "The effect of propranolol and flusoxolol on the lysosomal enzyme activity of the rat ventricular myocardium". Eksperimental'naia i klinicheskaia farmakologiia. 55 (5): 33–6. PMID 1363945.